Next-Generation Sequencer Analysis of Pulmonary Pleomorphic Carcinoma With a CD74-ROS1 Fusion Successfully Treated With Crizotinib

J Thorac Oncol. 2019 May;14(5):e106-e108. doi: 10.1016/j.jtho.2019.01.005.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antigens, Differentiation, B-Lymphocyte / metabolism*
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Crizotinib / pharmacology
  • Crizotinib / therapeutic use*
  • Female
  • High-Throughput Nucleotide Sequencing / methods*
  • Histocompatibility Antigens Class II / metabolism*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / pathology
  • Middle Aged

Substances

  • Antigens, Differentiation, B-Lymphocyte
  • Antineoplastic Agents
  • Histocompatibility Antigens Class II
  • invariant chain
  • Crizotinib